Published on January 24, 2022
Highlights: YoY comparison
Particular | Q3FY21 | Q3FY22 | Growth | 9MFY21 | 9MFY22 | Growth | |
Revenue | 222 | 422 | 91% | 570 | 1,052 | 85% | |
EBITDA | 68 | 141 | 107% | 181 | 334 | 85% | |
PAT | 25 | 70 | 184% | 68 | 154 | 126% |
The company has delivered a strong operating and financial performance in line with its commitment of growth. The key performance highlights are:
OPERATIONAL HIGHLIGHTS:
9MFY22 FINANCIAL HIGHLIGHTS:
Q3FY22 FINANCIAL HIGHLIGHTS:
STRATEGIC UPDATE:
o Crisil upgraded credit rating from A+/Positive to AA-/Stable
o Expansion projects on track for completion as per schedule: ECH – 90%, CPVC Resin – 80% and Caustic Soda – 80%
o In 9MFY22, the Company spent ₹ 365 Cr for expansion of all 3 projects
o We are expanding into Chlorotoluene & its value chain; establishing the R&D facility
Commenting on the results Mr Maulik Patel; Chairman and Managing Director – MFL said: We are glad to report a good performance during the quarter. We have achieved the highest ever topline for 9 months of ₹ 1,052 Cr. The commissioning and optimal utilisation of CMS & H2O2 drove our revenue & profit growth. The investments undertaken in the last couple of years for diversification of products continue to drive growth and increase our competitiveness.
The forward & backward integration expansion plan covering ECH, CPVC, Caustic soda and Captive power is progressing as per plan and will be commissioned as per schedule. We are simultaneously ensuring a sound financial, healthy cash generation and strong liquidity to ensure that we continue to meet all our obligations and commitments timely.
Further in line for continuous growth we have announced our expansion in Chlorotoluene & its value chain and setting up R&D facility, this will help to further strengthen our fully integrated complex. We continue to move forward in our strategic direction of scalability, strengthening integration & achieving lowest cost of operations.